Search

everythinglearnresearchcommunity

for

Search:↓

Oxidative stress contributes to hair graying and loss as we age.

Overexpressing Dsg3 in mice skin causes excessive cell growth and abnormal skin development.

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Minoxidil promotes hair growth but stops working when discontinued.

Teriflunomide is safe and tolerable for treating relapsing-remitting multiple sclerosis, with manageable side effects.

Some breast cancer patients still experience hair loss three years after chemotherapy, especially with taxane-based treatments.

Alopecia common in teens, may indicate endocrine issue, minoxidil effective treatment.

Hair loss in women often doesn't follow a pattern, isn't linked to age, may be genetic, and can be related to thyroid issues or other health factors.

Men's hair loss is caused by hormones and genes, and can be treated with medication and surgery, while graying is due to aging and has no prevention except dyeing.

Genetic and environmental factors, like smoking and exercise, affect male hair loss.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Hair becomes gray and thin as we age, and while most hair loss in older people is due to genetics, there's a chance for gray hair to regain color under certain conditions.

Hair bleaching causes significant damage to hair and skin.

Frontal fibrosing alopecia can cause sudden hair loss on limbs, similar to scalp hair loss.

Diagnosing diffuse alopecia, a hair loss condition, can be challenging and may require a scalp biopsy or tracking the disease's progression when symptoms and skin tests aren't enough.

Some psychiatric medications can cause reversible hair loss.

Hair loss affects both genders and can impact well-being, with treatments available for various types.

Chemotherapy can cause rapid, extensive hair loss, with patterns varying between individuals.

Chronic exposure to sunlight may worsen male pattern baldness and protecting the scalp from the sun could slow it down.

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

Facial aging is caused by natural processes and external factors, and can be managed with preventative measures and a variety of treatments tailored to individual needs.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Vemurafenib therapy can cause hair loss, but clobetasol propionate foam can help regrow hair.

Testosterone therapy helped 63% of androgen-deficient women grow scalp hair, but more research is needed.

Teriflunomide effectively reduces relapses and disability in MS and has a manageable safety profile.

The new synthetic retinoid RO 13-6298 effectively treated severe psoriasis at low doses with manageable side effects.

The authors suggest that a new type of hair loss exists, which is different from alopecia areata.

The research found that a specific gene mutation causes fewer hair follicles and disrupted hair growth cycles, leading to thin and short hair in people with Hypotrichosis with Juvenile Macular Dystrophy.

Teriflunomide is an effective and safe first-line oral treatment for relapsing multiple sclerosis.